Clinical Report: Hantavirus Cardiopulmonary Syndrome in Chile
Background
Hantavirus cardiopulmonary syndrome (HCPS) is a critical illness characterized by rapid progression to respiratory failure and shock, with a high case fatality rate of approximately 30-45%.
Data Highlights
Parameter
Value
Total Patients
31
Male Patients
71%
Median Age
44 years
Overall Mortality
16.1%
Patients Requiring ECMO
25.8%
Renal Replacement Therapy in Severe Cases
13.3%
Transfusion Requirements in Severe Cases
46.7%
Key Findings
22.6% of patients required non-invasive ventilation (NIV).
Severe cases accounted for all in-hospital deaths.
Renal replacement therapy (RRT) was required in 13.3% of severe cases.
Transfusion requirements were observed in 46.7% of severe cases.
Clinical Implications
The findings highlight the critical need for advanced organ support in HCPS patients, particularly the role of ECMO in severe cases. Timely escalation to extracorporeal support may be crucial for improving patient outcomes.
Conclusion
HCPS presents significant challenges in critical care, with high mortality rates and substantial organ support needs, underscoring the importance of prompt recognition and management.
